Deguelin inhibits the proliferation of human multiple myeloma cells by inducing apoptosis and G2/M cell cycle arrest: Involvement of Akt and p38 MAPK signalling pathway

Deguelin exhibits antiproliferative activity against various cancer cell types. Previous studies have reported that deguelin exhibits pro-apoptotic activity against human cancer cells. The current study aimed at further elaborating the anticancer effects of deguelin against multiple myeloma cells. C...

Full description

Saved in:
Bibliographic Details
Main Authors: Sun Kening, Chen Ping, Zhang Liang, Lu Zhidong, Jin Qunhua
Format: Article
Language:English
Published: Sciendo 2024-03-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.2478/acph-2024-0003
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832557663126290432
author Sun Kening
Chen Ping
Zhang Liang
Lu Zhidong
Jin Qunhua
author_facet Sun Kening
Chen Ping
Zhang Liang
Lu Zhidong
Jin Qunhua
author_sort Sun Kening
collection DOAJ
description Deguelin exhibits antiproliferative activity against various cancer cell types. Previous studies have reported that deguelin exhibits pro-apoptotic activity against human cancer cells. The current study aimed at further elaborating the anticancer effects of deguelin against multiple myeloma cells. Cell growth estimations were made through MTT assay. Phase contrast microscopy was used for the analysis of the viability of multiple myeloma cells. Colony formation from multiple myeloma cells was studied using a clonogenic assay. Antioxidative assays for determining levels of glutathione (GSH) and superoxide dismutase (SOD) were carried out after treating multiple myeloma cells with deguelin. The apoptosis of multiple myeloma cells was studied using AO/EB and Annexin V-FITC/PI staining methods. Multiple myeloma cell cycle analysis was performed through flow cytometry. mRNA expression levels were depicted using qRT-PCR. Migration and invasion of multiple myeloma cells were determined with the wound-healing and transwell assays, respectively. Deguelin specifically inhibited the multiple myeloma cell growth while the normal plasma cells were minimally affected. Multiple myeloma cells when treated with deguelin exhibited remarkably lower viability and colony-forming ability. Multiple myeloma cells treated with deguelin produced more SOD and had higher GSH levels. The multiple myeloma cell growth, migration, and invasion were significantly declined by in vitro administration of deguelin. In conclusion, deguelin treatment, when applied in vitro, induced apoptotic cell death and resulted in mitotic cessation at the G2/M phase through modulation of cell cycle regulatory mRNAs in multiple myeloma cells.
format Article
id doaj-art-bb845dec25ef4f4c8b08555fc3f8320b
institution Kabale University
issn 1846-9558
language English
publishDate 2024-03-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-bb845dec25ef4f4c8b08555fc3f8320b2025-02-03T03:22:45ZengSciendoActa Pharmaceutica1846-95582024-03-0174110111510.2478/acph-2024-0003Deguelin inhibits the proliferation of human multiple myeloma cells by inducing apoptosis and G2/M cell cycle arrest: Involvement of Akt and p38 MAPK signalling pathwaySun Kening0Chen Ping1Zhang Liang2Lu Zhidong3Jin Qunhua4Department of OrthopedicsWard 3 The General Hospital of Ningxia Medical University, Yinchuan Ningxia, ChinaMedical Experiment Center, General Hospital of Ningxia Medical University, Ningxia, ChinaDepartment of OrthopedicsWard 3 The General Hospital of Ningxia Medical University, Yinchuan Ningxia, ChinaDepartment of OrthopedicsWard 3 The General Hospital of Ningxia Medical University, Yinchuan Ningxia, ChinaDepartment of OrthopedicsWard 3 The General Hospital of Ningxia Medical University, Yinchuan Ningxia, ChinaDeguelin exhibits antiproliferative activity against various cancer cell types. Previous studies have reported that deguelin exhibits pro-apoptotic activity against human cancer cells. The current study aimed at further elaborating the anticancer effects of deguelin against multiple myeloma cells. Cell growth estimations were made through MTT assay. Phase contrast microscopy was used for the analysis of the viability of multiple myeloma cells. Colony formation from multiple myeloma cells was studied using a clonogenic assay. Antioxidative assays for determining levels of glutathione (GSH) and superoxide dismutase (SOD) were carried out after treating multiple myeloma cells with deguelin. The apoptosis of multiple myeloma cells was studied using AO/EB and Annexin V-FITC/PI staining methods. Multiple myeloma cell cycle analysis was performed through flow cytometry. mRNA expression levels were depicted using qRT-PCR. Migration and invasion of multiple myeloma cells were determined with the wound-healing and transwell assays, respectively. Deguelin specifically inhibited the multiple myeloma cell growth while the normal plasma cells were minimally affected. Multiple myeloma cells when treated with deguelin exhibited remarkably lower viability and colony-forming ability. Multiple myeloma cells treated with deguelin produced more SOD and had higher GSH levels. The multiple myeloma cell growth, migration, and invasion were significantly declined by in vitro administration of deguelin. In conclusion, deguelin treatment, when applied in vitro, induced apoptotic cell death and resulted in mitotic cessation at the G2/M phase through modulation of cell cycle regulatory mRNAs in multiple myeloma cells.https://doi.org/10.2478/acph-2024-0003multiple myelomadeguelinapoptosisg2/m cell cycle arrestmetastasisp38 mapk signalling pathway
spellingShingle Sun Kening
Chen Ping
Zhang Liang
Lu Zhidong
Jin Qunhua
Deguelin inhibits the proliferation of human multiple myeloma cells by inducing apoptosis and G2/M cell cycle arrest: Involvement of Akt and p38 MAPK signalling pathway
Acta Pharmaceutica
multiple myeloma
deguelin
apoptosis
g2/m cell cycle arrest
metastasis
p38 mapk signalling pathway
title Deguelin inhibits the proliferation of human multiple myeloma cells by inducing apoptosis and G2/M cell cycle arrest: Involvement of Akt and p38 MAPK signalling pathway
title_full Deguelin inhibits the proliferation of human multiple myeloma cells by inducing apoptosis and G2/M cell cycle arrest: Involvement of Akt and p38 MAPK signalling pathway
title_fullStr Deguelin inhibits the proliferation of human multiple myeloma cells by inducing apoptosis and G2/M cell cycle arrest: Involvement of Akt and p38 MAPK signalling pathway
title_full_unstemmed Deguelin inhibits the proliferation of human multiple myeloma cells by inducing apoptosis and G2/M cell cycle arrest: Involvement of Akt and p38 MAPK signalling pathway
title_short Deguelin inhibits the proliferation of human multiple myeloma cells by inducing apoptosis and G2/M cell cycle arrest: Involvement of Akt and p38 MAPK signalling pathway
title_sort deguelin inhibits the proliferation of human multiple myeloma cells by inducing apoptosis and g2 m cell cycle arrest involvement of akt and p38 mapk signalling pathway
topic multiple myeloma
deguelin
apoptosis
g2/m cell cycle arrest
metastasis
p38 mapk signalling pathway
url https://doi.org/10.2478/acph-2024-0003
work_keys_str_mv AT sunkening deguelininhibitstheproliferationofhumanmultiplemyelomacellsbyinducingapoptosisandg2mcellcyclearrestinvolvementofaktandp38mapksignallingpathway
AT chenping deguelininhibitstheproliferationofhumanmultiplemyelomacellsbyinducingapoptosisandg2mcellcyclearrestinvolvementofaktandp38mapksignallingpathway
AT zhangliang deguelininhibitstheproliferationofhumanmultiplemyelomacellsbyinducingapoptosisandg2mcellcyclearrestinvolvementofaktandp38mapksignallingpathway
AT luzhidong deguelininhibitstheproliferationofhumanmultiplemyelomacellsbyinducingapoptosisandg2mcellcyclearrestinvolvementofaktandp38mapksignallingpathway
AT jinqunhua deguelininhibitstheproliferationofhumanmultiplemyelomacellsbyinducingapoptosisandg2mcellcyclearrestinvolvementofaktandp38mapksignallingpathway